Previous Page  186 / 194 Next Page
Information
Show Menu
Previous Page 186 / 194 Next Page
Page Background

184

http://www.DGS-PraxisLeitlinien.de

Nr.

Nachweis

273

Ross-Lee L, Heazlewood V, Tyrer JH, Eadie MJ. Aspirin treatment of migraine attacks:

plasma drug level data. Cephalalgia. 1982 Mar;2(1):9-14.

274

Rote Liste online: Dociton®, Stand Dezember 2013

275

Rozen TD, Fishman RS. Demand valve oxygen: a promising new oxygen delivery system

for the acute treatment of cluster headache. Pain Med. 2013 Apr;14(4):455-9.

276

Rozen TD, Fishman RS. Inhaled oxygen and cluster headache sufferers in the United Sta-

tes: use, efficacy and economics: results from the United States Cluster Headache Survey.

Headache. 2011 Feb;51(2):191-200.

277

Rozen TD. Inhaled Oxygen for Cluster Headache: Efficacy, Mechanism of Action, Utilizati-

on, and Economics. Curr Pain Headache Rep. 2012 Jan 29.

278

Rozen TD. Migraine Headache: Immunosuppressant Therapy. Curr Treat Options Neurol.

2002 Sep;4(5):395-401.

279

Russell MB. Epidemiology and genetics of cluster headache. Lancet Neurol. 2004

May;3(5):279-83. Review.

280

Salonen R, Saiers J. Sumatriptan is effective in the treatment of menstrual migraine: a

review of prospective studies and retrospective analyses. Cephalalgia. 1999 Jan;19(1):16-

9. Review.

281

Sances G, Galli F, Ghiotto N, Allena M, Guaschino E, Frustaci A, Nappi G, Tassorelli C.

Factors associated with a negative outcome of medication-overuse headache: a 3-year

follow-up (the 'CARE' protocol). Cephalalgia. 2013 May;33(7):431-43.

282

Sances G, Ghiotto N, Galli F, Guaschino E, Rezzani C, Guidetti V, Nappi G. Risk factors in

medication-overuse headache: a 1-year follow-up study (care II protocol). Cephalalgia.

2010 Mar;30(3):329-36.

283

Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G. Naproxen sodium

in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache.

1990 Nov;30(11):705-9.

284

Sanders M, Zuurmond WW. Efficacy of sphenopalatine ganglion blockade in 66 patients

suffering from cluster headache: a 12- to 70-month follow-up evaluation. J Neurosurg.

1997 Dec;87(6):876-80.

285

Sandrini G, Perrotta A, Tassorelli C, Torelli P, Brighina F, Sances G, Nappi G. Botulinum

toxin type-A in the prophylactic treatment of medication-overuse headache: a multicen-

ter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain.

2011 Aug;12(4):427-33.

286

Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ; ONSTIM Inves-

tigators. Occipital nerve stimulation for the treatment of intractable chronic migraine

headache: ONSTIM feasibility study. Cephalalgia. 2011 Feb;31(3):271-85.

287

Saper JR, Lake AE 3rd, Cantrell DT, Winner PK, White JR. Chronic daily headache prophy-

laxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.

Headache. 2002 Jun;42(6):470-82.